About Neovasc (TSE:NVC)
Neovasc Inc. (Neovasc) is a specialty medical device company. The Company develops, manufactures and markets products for the cardiovascular marketplace. The Company's segment is the development, manufacture and marketing of medical devices. Its products include the Tiara technology in development for the transcatheter treatment of mitral valve disease, the Neovasc Reducer for the treatment of refractory angina, and tissue products. The Tiara is in preclinical/early clinical stage development to provide a minimally invasive transcatheter device for patients experiencing mitral regurgitation (MR) as a result of mitral heart valve disease. The Reducer is an hourglass-shaped, balloon-expandable, stainless steel, bare metal device, which is implanted in the coronary sinus, creating a restriction in venous outflow from the myocardium (the muscular layer of the heart wall). Neovasc produces Peripatch, a biological tissue product that is manufactured from pericardium.
Industry, Sector and Symbol
Trailing P/E Ratio4.56410256410256
Forward P/E RatioN/A
Sales & Book Value
Price / SalesN/A
Price / CashN/A
Price / BookN/A
Return on EquityN/A
Return on Assets-22.34%
Neovasc (TSE:NVC) Frequently Asked Questions
What is Neovasc's stock symbol?
Neovasc trades on the Toronto Stock Exchange (TSX) under the ticker symbol "NVC."
When will Neovasc make its next earnings announcement?
Who are some of Neovasc's key competitors?
Some companies that are related to Neovasc include Platinum Group Metals (PTM), Colabor Group (GCL), Tree Island Steel (TSL), Glacier Media (GVC), Nexj Systems (NXJ), Petrus Resources (PRQ), Journey Energy (JOY), Trimel Pharmaceuticals (ASP), Fortress Paper (FTP), Trez Capital Mortgage Investment (TZZ), Concordia International (CXR), Perpetual Energy (PMT), Chinook Energy (CKE), Primero Mining (P), TAG Oil (TAO), McCoy Global (MCB), Canadian Zinc (CZN) and Foraco International (FAR).
Who are Neovasc's key executives?
Neovasc's management team includes the folowing people:
- Paul L. Geyer, Independent Chairman of the Board
- Fred Colen, President, Chief Executive Officer
- Christopher Clark, Chief Financial Officer, Corporate Secretary
- Brian McPherson, Chief Operating Officer
- Vicki Lee Bebeau, Vice President - Clinical Affairs
- Randy Lane, Vice President - Research & Development
- Alexei J. Marko, Director
- Jane H. Hsiao Ph.D., Independent Director (Age 69)
- Douglas Glen Janzen, Independent Director
- William O'Neill, Independent Director (Age 61)
How do I buy Neovasc stock?
Shares of Neovasc and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.
What is Neovasc's stock price today?
One share of Neovasc stock can currently be purchased for approximately C$1.78.
How big of a company is Neovasc?
Neovasc has a market capitalization of C$36.34 million.
How can I contact Neovasc?
Neovasc's mailing address is 13562 Maycrest Way Suite 5138, RICHMOND, BC V6V 2J7, Canada. The company can be reached via phone at +1-604-2704344.
MarketBeat Community Rating for Neovasc (NVC)MarketBeat's community ratings are surveys of what our community members think about Neovasc and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.
Neovasc (TSE:NVC) Analyst Ratings History
No equities research coverage for this company has been tracked by MarketBeat
Neovasc (TSE:NVC) Earnings History and Estimates Chart
Neovasc (TSE NVC) Earnings History by Quarter
(Earnings results data provided by Zacks Investment Research)
|Date||Quarter||Consensus Estimate||Actual EPS||Revenue Estimate||Actual Revenue||Release Link||Conference Call||Details|
|3/22/2018|| || || || || || || || |
Neovasc (TSE:NVC) Earnings Estimates
2018 EPS Consensus Estimate: $0.00
(Earnings estimates data provided by Zacks Investment Research)
|Quarter||Number of Estimates||Low Estimate||High Estimate||Average Estimate|
Dividend History for Neovasc (TSE:NVC)
No dividend announcements for this company have been tracked by MarketBeat.com
Insider Trading History for Neovasc (TSE NVC)
No insider trades for this company have been tracked by MarketBeat.com
Neovasc (TSE NVC) News Headlines
Neovasc (TSE:NVC) SEC Filings
This page is loading this company's SEC Filings. Please wait...
Financials are not available for this stock.
Neovasc (TSE NVC) Stock Chart for Thursday, February, 22, 2018